WallStreetZenWallStreetZen

NASDAQ: ZVRA
Zevra Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Zevra Therapeutics earnings were $58.3M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest ZVRA earnings report on Jun 30, 2026 announced Q2 2026 earnings of $8.8M, down 76.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ZVRA reported annual earnings of $83.2M, with -178.9% growth.

ZVRA earnings history

Current Revenue
$136.1M
Current Earnings
$58.3M
Current Profit Margin
42.8%

ZVRA Return on Equity

Current Company
32.8%
Current Industry
-13.7%
Current Market
29%
ZVRA's Return on Equity (32.8%)... subscribe to Premium to read more.
High Return on Equity Performance

ZVRA Return on Assets

Current Company
20.5%
Current Industry
-10.4%
ZVRA is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ZVRA announces earnings.

ZVRA Return on Capital Employed

Current Company
29.52%
Current Industry
-6.8%
ZVRA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ZVRA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ZVRA$77.33M$58.26MN/A$0.95
RGNX-$139.12M-$196.43MN/A-$3.79
ASMB$68.00k-$42.00kN/A$1.02
CTMX-$73.69M-$82.66MN/A-$0.50
PHAT-$35.14M-$99.07MN/A-$1.26
View Top Biotech Stocks

Zevra Therapeutics Earnings Reports & History FAQ

What were Zevra Therapeutics's earnings last quarter?

On ZVRA's earnings call on Aug 5, 2026, Zevra Therapeutics (NASDAQ: ZVRA) reported Q2 2026 earnings per share (EPS) of $0.14, up 88.71% year over year. Total ZVRA earnings for the quarter were $8.75 million. In the same quarter last year, Zevra Therapeutics's earnings per share (EPS) was $1.24.

If you're new to stock investing, here's how to buy Zevra Therapeutics stock.

Is Zevra Therapeutics profitable or losing money?

As of the last Zevra Therapeutics earnings report, Zevra Therapeutics is currently profitable. Zevra Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $58.26 million, a 2,103.59% increase year over year.

What was ZVRA's earnings growth in the past year?

As of Zevra Therapeutics's earnings date in Aug 5, 2026, Zevra Therapeutics's earnings has grown year over year. ZVRA earnings in the past year totalled $58.26 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.